Fractyl Health GUTS
NASDAQ GUTS
$0.78 +0.09 (+13.85%)
At close: Aug 21, 2026 · 4:00 PM EDT

Fractyl Health (GUTS) Change in Accured Expenses (2023 - 2026)

Fractyl Health's (GUTS) quarterly Change in Accured Expenses came in at -$2.9 million in Q1 2026, down 475.51% YoY from $780000.0 in Q1 2025, and down 1633.14% on a QoQ basis from -$169000.0 in Q4 2025.

Fractyl Health (GUTS) Change in Accured Expenses (2023 - 2026) Analysis & Trends

Fractyl Health (GUTS) has 4 years of Change in Accured Expenses data on file, last reported at -$2.9 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 475.51% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (down 192.04% YoY) and the FY2025 annual result came in at $414000.0, down 92.68% from the prior year.
  • Change in Accured Expenses fell to -$2.9 million in Q1 2026, from -$169000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q1 2024 to a low of -$2.9 million in Q1 2026.
  • A 4-year average of $283230.8 and a median of $367000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2024 — Change in Accured Expenses surged 2430.77% — and 2026, when it sank 475.51%.
  • Tracing GUTS's Change in Accured Expenses over 4 years: stood at $367000.0 in 2023, then jumped by 613.35% to $2.6 million in 2024, then plunged by 106.46% to -$169000.0 in 2025, then sank by 1633.14% to -$2.9 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$2.9 million (Q1 2026), -$169000.0 (Q4 2025), and -$811000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Fractyl Health 123.81 Mn 123.81 Mn - 1.04 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.04 Mn
Jun 30, 2026 1.04 Mn
Mar 31, 2026 -2.93 Mn
Mar 31, 2026 -2.93 Mn
Dec 31, 2025 -169,000.00
Dec 31, 2025 -169,000.00
Sep 30, 2025 -811,000.00
Sep 30, 2025 -811,000.00
Jun 30, 2025 614,000.00
Jun 30, 2025 614,000.00
Mar 31, 2025 780,000.00
Mar 31, 2025 780,000.00
Dec 31, 2024 2.62 Mn
Dec 31, 2024 2.62 Mn
Sep 30, 2024 1.97 Mn
Sep 30, 2024 1.97 Mn
Jun 30, 2024 -1.79 Mn
Jun 30, 2024 -1.79 Mn
Mar 31, 2024 2.85 Mn
Mar 31, 2024 2.85 Mn